Literature DB >> 33145682

The Importance of Learning Health Systems in Addressing the Opioid Crisis.

Wilson M Compton1, Tisha Wiley2, Carlos Blanco2.   

Abstract

Interventions and research to address the US opioid crisis have, for the most part, targeted opioid use, misuse, and addiction specifically. While such a focus can lead to useful innovations in the care of opioid use disorder, the fact that many persons with opioid use disorder use multiple substances (both over their life course and simultaneously in drug-using episodes) makes it imperative to address broader issues of addiction in persons who have opioid use disorder as their presenting concern. Because of integrated care and the ability to target multiple clinical concerns in parallel, the Veterans Administration (VA) may be uniquely situated to address the key issue of multi-morbidity that persons with opioid use disorder so frequently exhibit. Research at the VA can build on new interventions developed by the National Institutes of Health (and others) and can help to determine the best ways to implement these interventions. Research at the VA does not need to duplicate efforts supported by other funders but can complement such work by providing an integrated platform for determining the best approaches to implementing innovations. The real-world learning health system that has been developed in the VA is poised to contribute in just such important ways.

Entities:  

Mesh:

Year:  2020        PMID: 33145682      PMCID: PMC7728900          DOI: 10.1007/s11606-020-06267-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  29 in total

1.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

2.  Helping to End Addiction Over the Long-term: The Research Plan for the NIH HEAL Initiative.

Authors:  Francis S Collins; Walter J Koroshetz; Nora D Volkow
Journal:  JAMA       Date:  2018-07-10       Impact factor: 56.272

3.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

4.  Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.

Authors:  Christopher M Jones; Jana K McAninch
Journal:  Am J Prev Med       Date:  2015-07-03       Impact factor: 5.043

5.  Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013.

Authors:  Christopher M Jones; Peter G Lurie; Wilson M Compton
Journal:  Am J Public Health       Date:  2016-02-18       Impact factor: 9.308

6.  Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science.

Authors:  Andrea K Finlay; Ingrid A Binswanger; Christine Timko; David Smelson; Matthew A Stimmel; Mengfei Yu; Tom Bowe; Alex H S Harris
Journal:  J Subst Abuse Treat       Date:  2018-10-02

7.  Nationwide dissemination of contingency management: the Veterans Administration initiative.

Authors:  Nancy M Petry; Dominick DePhilippis; Carla J Rash; Michelle Drapkin; James R McKay
Journal:  Am J Addict       Date:  2014 May-Jun

8.  Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.

Authors:  Andrea K Finlay; Alex H S Harris; Joel Rosenthal; Jessica Blue-Howells; Sean Clark; Jim McGuire; Christine Timko; Susan M Frayne; David Smelson; Elizabeth Oliva; Ingrid Binswanger
Journal:  Drug Alcohol Depend       Date:  2016-01-24       Impact factor: 4.492

9.  Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

Authors:  Jean Y Ko; Stephen W Patrick; Van T Tong; Roshni Patel; Jennifer N Lind; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-12       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.